To gain further insight, we performed transcriptome sequencing on several AML and ALL cell lines and primary samples, which revealed higher expression of inhibitory ligands/receptors, including B7-H3, TIM3, and CD155 in AML cell lines and primary samples (Fig. 3A). This evidence concerns the gene CD276 and acute myeloid leukemia.